Topics

Brineura Cleared By England's NICE For Ultra-Rare Batten Disease

08:35 EDT 12 Sep 2019 | Elsevier Business Intelligence

NICE has recommended BioMarin’s Brineura for use in the National Health Service in England after a managed access deal and....

Original Article: Brineura Cleared By England's NICE For Ultra-Rare Batten Disease

NEXT ARTICLE

More From BioPortfolio on "Brineura Cleared By England's NICE For Ultra-Rare Batten Disease"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...